by Benjamin H. Rudolph, Aptagen, Inc. Having a big name on your team isn't enough, but it sure helps!
Benjamin H. Rudolph
Advertisement
Articles by Benjamin H. Rudolph
by Benjamin H. Rudolph, Aptgen, Inc. What's an investor to do when previously rock-solid investments suddenly aren't?
by Benjamin H. Rudolph and Viqar Aslam, Aptagen, Inc. One company shows the world that stem cell research isn't coing away -- and receives a worldwide ctroversy in the process.
Advertisement
Latest Updated Articles
- Your Vested Interests: The War of the West
January 15th 2002
- The Not-So-Sure Thing
May 15th 2002
- Your Vested Interests: Gorillas In Our Midst
August 15th 2002
Advertisement
Advertisement
Trending on BioPharm International
1
ImvivaBio’s Dual-Target Allogeneic CAR-T Sustains Lupus Remission Through 12 Months
2
Updates on Simtra BioPharma Solutions’ Bloomington Capacity Expansions
3
Blackstone to Provide Pfizer Up to $1.5 Billion for Monthly GLP-1 Berobenatide Development
4
Amgen’s Dazodalibep Reduces Systemic Disease Activity in Phase 3 Sjögren’s Trial
5